Omega-6:Omega-3 Test

Your standard cholesterol panel tells you how much fat is moving through your blood. It tells you nothing about the kind of fat built into every cell membrane in your body, or whether that fat is tipping your biology toward chronic inflammation or away from it. The omega-6:omega-3 ratio answers that question directly.

This single number captures the tug of war between two families of essential fats. When the ratio is high, your cells are loaded with raw materials that feed inflammatory signaling. When it is lower, the balance shifts toward resolution and repair. In a study of over 85,000 UK adults followed for more than a decade, those in the highest fifth of this ratio had about 26% higher risk of dying from any cause and 31% higher risk of dying from heart disease compared to the lowest fifth.

What This Ratio Actually Measures

Omega-6 and omega-3 are two families of polyunsaturated fatty acids (PUFAs), a type of fat your body cannot make on its own. You get them entirely from food. Omega-6 fats, led by linoleic acid (found in vegetable oils, nuts, and seeds), are converted into signaling molecules that ramp up inflammation when your body needs it. Omega-3 fats, led by EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) from fatty fish and seafood, produce signaling molecules that cool inflammation down and help tissues heal.

Both families compete for the same processing enzymes in your liver and cells. When omega-6 dominates your diet and your cell membranes, the enzymes churn out more pro-inflammatory signals and fewer anti-inflammatory ones. The ratio measures this competition directly: it tells you which team is winning inside your cells.

This test uses whole blood, which reflects fatty acids from both your plasma (recent intake) and your red blood cell membranes (a longer window of weeks to months). That makes it more stable than a plasma-only snapshot and gives you a better picture of your habitual dietary pattern.

Heart Disease and Mortality Risk

The cardiovascular signal from this ratio is consistent and large. In the UK Biobank, a prospective study tracking over 85,000 adults for roughly 11 to 13 years, people in the highest fifth of the plasma omega-6/omega-3 ratio (a related but not identical measurement to the whole-blood ratio this test reports) were about 26% more likely to die from any cause, about 31% more likely to die from cardiovascular disease, and about 14% more likely to die from cancer, compared to those in the lowest fifth. These associations held after adjusting for standard lifestyle and clinical risk factors.

A separate analysis of over 35,000 UK Biobank participants who already had cardiovascular disease found an even steeper gradient. Those in the top quarter of the ratio had about 41% higher all-cause mortality and 36% higher cardiovascular mortality than those in the bottom quarter.

Adding the omega-6/omega-3 ratio to a standard cardiovascular risk calculator (called SCORE2, a tool European guidelines use to estimate your 10-year risk of a major heart event) modestly but significantly improved its accuracy in a cohort of over 183,000 middle-aged adults. The benefit was strongest in men. This means the ratio is capturing something about your risk that cholesterol, blood pressure, and the usual suspects miss.

Stroke Risk

In the Adventist Health Study 2, which followed roughly 78,000 adults for up to 10 years, a higher dietary omega-6/omega-3 ratio (estimated from food questionnaires rather than a blood test) was tied to about 40% greater risk of fatal stroke when comparing the 90th percentile to the 10th percentile. Even after adjusting for total omega-3 intake, the ratio remained a significant predictor, suggesting the balance between the two fat families matters above and beyond simply eating more fish.

Type 2 Diabetes

A cross-sectional study (a snapshot of a group at one point in time) of about 8,700 adults found that those with higher dietary omega-6 to omega-3 ratios had significantly greater odds of type 2 diabetes, while those with the highest omega-3 intake had about 58% lower odds. The ratio appears to track something about metabolic health that fasting glucose alone does not capture. In a smaller study of 72 middle-aged adults, a higher plasma omega-6/omega-3 ratio was linked to higher insulin resistance, worse cholesterol profiles, and signs of liver stress.

That said, a large meta-analysis (a study that pools results from many separate trials) of randomized trials found that simply increasing omega-3, omega-6, or total polyunsaturated fat intake had little or no direct effect on preventing or treating type 2 diabetes. The ratio likely reflects a broader dietary and metabolic pattern rather than a single lever you can pull.

Colorectal Cancer

In the EPIC cohort (European Prospective Investigation into Cancer and Nutrition), which followed over 521,000 adults for a median of about 15 years, a higher dietary ratio of long-chain omega-6 to omega-3 fats was associated with about 31% higher colorectal cancer risk when comparing the top fifth to the bottom fifth. Separate UK Biobank analyses showed modest inverse associations between both omega-3 and omega-6 blood levels and overall cancer incidence, but the ratio itself was positively associated with cancer risk.

Depression and Mood Disorders

A meta-analysis pooling 12 prospective studies and over 66,000 participants found that a high omega-6/omega-3 ratio was associated with about 21% higher risk of developing depression. The signal was strongest for dietary ratio studies. In a 7-year follow-up of 69 young people at high risk for psychiatric illness, a higher red blood cell omega-6/omega-3 ratio at baseline predicted future mood disorders, independent of symptoms at the time of testing.

A separate Mendelian randomization analysis (a technique that uses genetic data to test whether an observed link is likely to reflect a true cause-and-effect relationship) of nearly 30,000 people suggested that increased omega-6/omega-3 ratio may be causally related to major depressive disorder. However, large randomized trials of omega-3 supplements have generally shown little effect on preventing depression in the general population. The ratio may be more useful for identifying risk than for predicting response to supplements.

Eye Health

In a study of about 4,500 Korean adults, women with a higher dietary omega-6/omega-3 ratio had significantly greater prevalence of age-related macular degeneration (AMD), a leading cause of vision loss. This association was not seen in men. If you are a woman concerned about long-term eye health, this is another reason to pay attention to this number.

Chronic Pain

A study of about 500 adults found that a higher circulating omega-6/omega-3 ratio was associated with greater odds of both temporomandibular disorder (TMD, a common jaw pain condition) and chronic low back pain. A related analysis of about 500 people with TMD and irritable bowel syndrome (IBS) found that higher ratios tracked with more somatic symptoms and more severe depressive symptoms. The anti-inflammatory signaling molecules that come from omega-3 fats appear to play a direct role in pain processing, not just inflammation.

Nuance: Omega-6 Is Not the Enemy

A common oversimplification is that omega-6 fats are inherently harmful and that you should slash them as aggressively as possible. The evidence does not support this. A massive pooled analysis of 30 cohorts and nearly 69,000 people found that higher blood levels of linoleic acid (the main omega-6 fat) were associated with lower total cardiovascular risk, about 22% lower cardiovascular mortality, and 12% lower ischemic stroke risk. Arachidonic acid (another omega-6) was not harmful and possibly modestly protective.

Similarly, a pooled analysis of 20 cohorts and nearly 40,000 adults found that higher linoleic acid levels were associated with 35% lower risk of type 2 diabetes, and this was not modified by omega-3 levels. An umbrella meta-analysis of 150 cohorts confirmed that higher dietary and circulating omega-6 was generally associated with lower risks of cardiovascular disease, cancer, and all-cause mortality.

So both sides of this ratio matter, but in practice, most people's ratio is high because omega-3 intake is low, not because omega-6 intake is dangerously high. The most effective strategy for almost everyone is to increase omega-3, not to fear omega-6.

Reference Ranges

No major guideline body has set formal clinical cutpoints for the omega-6/omega-3 ratio. Major agencies like the WHO, AHA, and EFSA set absolute intake recommendations for individual fatty acids (linoleic acid, alpha-linolenic acid, EPA, and DHA), not ratio thresholds. The numbers below come from large population studies and should be treated as orientation, not rigid targets. Your own lab may report values in slightly different units depending on the specimen and method used.

These ranges come from whole-blood dried blood spot samples across more than 590,000 people globally. Dietary intake ratios tend to run higher than blood-based ratios because not all dietary fat is incorporated into cell membranes equally. Compare your results within the same lab and specimen type over time for the most meaningful trend.

Tracking Your Trend

A single reading of this ratio is useful. A trend over time is far more powerful. Your omega-6/omega-3 ratio reflects weeks to months of dietary habits (especially the red blood cell membrane component), so it will not swing wildly day to day. But it will shift meaningfully over 2 to 3 months if you make real changes to your fat intake.

Get a baseline test now. If your ratio is above 6:1 and you start increasing your omega-3 intake (through diet, supplements, or both), retest in 3 months to see if the number is moving. After that, test at least annually to confirm you are holding your gains. If you are already in the 3:1 to 6:1 range, annual testing is enough to make sure your habits are working.

Tracking the trend also protects you from overreacting to a single reading. Your ratio can be influenced by recent dietary patterns, supplement adherence, and even genetic variation in the enzymes (called FADS1 and FADS2) that convert these fats into their active forms. A single number without context is just a snapshot. Two or three readings over a year tell you whether your trajectory is headed in the right direction.

When Results Can Be Misleading

Because this test reflects membrane-level fat composition, it is less vulnerable to the acute confounders that plague many blood tests. A single meal or a stressful day will not meaningfully change your ratio. However, a few things can throw off interpretation:

• Recent omega-3 supplement loading: If you just started a high-dose fish oil supplement in the past week or two, your plasma levels may shift before your red blood cell membranes have caught up. The result may look better than your true baseline. For the most accurate read, test either before starting supplements or at least 8 to 12 weeks after a consistent dose.
• Genetic variation in fat-processing enzymes: Variants in the FADS gene cluster (which codes for the enzymes that convert dietary fats into their longer-chain, active forms) can shift your ratio independent of diet. Some people convert omega-6 to arachidonic acid more efficiently, which raises the ratio even with reasonable omega-3 intake.
• Specimen type mismatch: Whole-blood ratios, plasma ratios, and red blood cell membrane ratios are related but not identical. A ratio of 4:1 in whole blood is not the same as 4:1 in plasma. Always compare your results to reference values from the same specimen type and, ideally, the same lab.

What to Do With an Abnormal Result

If your ratio comes back above 6:1, the first step is to look at the companion numbers: your individual omega-3 levels (EPA and DHA), your Omega-3 Index if available, and your AA:EPA ratio. These tell you whether the high ratio is being driven by low omega-3 (the most common scenario), unusually high omega-6, or both.

A ratio above 10:1 alongside a low Omega-3 Index (below 4%) puts you in a clearly unfavorable metabolic zone. At that point, consider pairing this result with standard cardiovascular markers like ApoB, hs-CRP (a sensitive measure of systemic inflammation), and HbA1c (a 3-month average of blood sugar). If those are also trending in the wrong direction, you are seeing convergent evidence of cardiometabolic risk that warrants both dietary change and closer follow-up.

If your ratio is mildly elevated (6:1 to 10:1) and your other markers look fine, dietary adjustment and a 3-month retest is a reasonable path. If the ratio stays stubbornly high despite consistent omega-3 intake, genetic variation in FADS enzymes may be playing a role, and a conversation with a lipidologist or nutrition-focused physician can help interpret the pattern.